Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to release growth hormone. It has been investigated extensively for its effects on growth hormone signaling, IGF-1 levels, and metabolic processes.

Unlike many research peptides, tesamorelin also has an FDA-approved prescription use for reducing excess abdominal fat in adults with HIV and lipodystrophy. That approved indication does not establish it as a general-purpose weight-loss treatment.

Product strength, formulation, storage requirements, and intended use should always be verified from the official manufacturer documentation and labeling.

Key Features:

• Synthetic GHRH analogue
• Acts on growth hormone-releasing hormone receptors
• Associated with GH and IGF-1 signaling
• Studied in endocrine and metabolic research
• Available in prescription formulations for specific approved uses
• Product specifications vary by manufacturer

Important Notice: Tesamorelin is a prescription medication for specific approved indications in certain jurisdictions. It should only be used under the direction of a licensed healthcare professional. Research-grade products are not intended for human consumption or self-administration.